Publication | Closed Access
A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors
174
Citations
0
References
1997
Year
Growth Factor ReceptorsCancer ResearchReceptor Tyrosine KinaseImmunologyErbb-2/her2 BlocksTumor-inhibitory Monoclonal AntibodiesImmunotherapyMedicineCell BiologyCell SignalingTumor MicroenvironmentTumor BiologyCancer Growth
No additional data available for this publication yet. Check back later!